EMBL Australia group leader Professor David Lynn has been appointed as interim director of a new $7 million state-of-the-art centre for genomics in South Australia that he played a vital role in championing.
The South Australian Genomics Centre (SAGC) opens on 1 July after more than a year of planning and millions of dollars in funding, including $2 million from Bioplatforms Australia (BPA) through the Australian Government’s National Collaborative Research Infrastructure Strategy.
Recommended Posts
